MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Ataxia: Clinical features"

  • MDS Virtual Congress 2020

    An unusual phenotype of spinocerebellar ataxia type 12

    K. Neeraja, V. Holla, S. Prasad, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

    Objective: To describe a case of spinocerebellar ataxia type 12 (SCA-12) with an unusual phenotype. Background: SCA-12 is a rare autosomal dominant cerebellar ataxia which…
  • MDS Virtual Congress 2020

    GAD65 antibody neurologic syndrome presenting with hemiparkinsonism

    R. Patel, N. Witek, P. Pinna, M. Afshari (Chicago, IL, USA)

    Objective: To describe a novel phenotype of glutamic acid decarboxylase-65 (GAD65) antibody-associated neurological disease in which an older patient initially presented with levodopa-unresponsive hemiparkinsonism and…
  • MDS Virtual Congress 2020

    Two cases of Ataxia Telangiectasia Like Disorder: phenotypic spectrum associated with MRE11 gene

    I. Raslan, P. Matos, V. Ciarlarello, C. Jaques, J. Pedroso, O. Barsottini (São Paulo, Brazil)

    Objective: In this study we show a couple of siblings with a progressive cerebellar ataxia associated with mutation in MRE11A. Our goal is to demonstrate…
  • MDS Virtual Congress 2020

    An uncommon clinical phenotype associated with ANO10 mutation

    D. Silva, L. Guedes, A. Caldas (Torres Vedras, Portugal)

    Objective: To describe a case with a homozygous c.132dupA ANO10 mutation. Background: Autosomal recessive cerebellar ataxia type 3 (ARCA3) is associated to ANO10 mutations. It…
  • MDS Virtual Congress 2020

    Clinical and genetic abnormalities in patients with Friedreich’s ataxia: A genotype-phenotype correlation

    I. Singh, I. Ahmed, S. Shaykya, A. Srivastava (New Delhi, India)

    Objective: To examine the possibility of molecular finding affecting FRDA phenotype, we studied the clinical features and ascertained the GAA repeat sizes in FRDA patients…
  • MDS Virtual Congress 2020

    Detecting Lower Extremity Ataxia: Toe-Heel Tap is the Best Screening Tool

    E. Smith, D. Whitney, D. Bhatti, A. Hellman, D.J Bertoni, D. Torres-Russotto (Omaha, NE, USA)

    Objective: Identify the most reliable bedside screening test for lower extremity ataxia. Background: Accurate identification of ataxia is critical for appropriate diagnosis and treatment. The…
  • MDS Virtual Congress 2020

    Clinical correlation with the Genotype of Friedreich’s Ataxia (FRDA) patients in Indian population

    A.K Srivastava, I. Ahmad, P. Sharma, M. Seth, U. Shamim, I. Singh, R. Rajan, M.P Srivastava, F. Mohammad (New Delhi, India)

    Objective: To describe genotype-phenotype correlation in Indian FRDA patients. Background: Friedreich’s Ataxia(FRDA), an early onset  rare autosomal recessive ataxia is caused by bi-allelic loss of…
  • MDS Virtual Congress 2020

    Reclassification of variant c.5825C>T and clinical evidence of variant c.3955_3958dup in a Peruvian family with ATM syndrome

    M. Cornejo-Olivas, R. Rodriguez, J. Bazalar-Montoya, E. Sarapura-Castro, M. Torres-Loarte, A.A Rivera-Valdivia, Y. Sullcahuaman-Allende (Lima, Peru)

    Objective: To describe a Peruvian family carrying variants c.3955_3958dup and c.5825C>T in the ATM gene. Background: Pathogenic variants at ATM gene are associated both, to…
  • MDS Virtual Congress 2020

    Gerstmann-Sträussler-Scheinker disease presenting as a late onset slowly progressive spinocerebellar ataxia: expanding the phenotypic spectrum of genetic prion disease

    C. Stephen, J. Chen, B. Appleby, T. Prior, M. Frosch, J. Schmahmann (Boston, MA, USA)

    Objective: We describe a late-onset presentation of Gerstmann-Sträussler-Scheinker disease (GSS) with a novel mutation in the prion protein (PRNP) gene. We compare this case to…
  • MDS Virtual Congress 2020

    Plasma biomarker quantification in SCA3 using the Neurology 4-PLEX A kit and the Simoa technology

    H. Garcia-Moreno, G. Thomas-Black, A. Heslegrave, H. Zetterberg, P. Giunti (London, United Kingdom)

    Objective: We present the results of plasma biomarker quantification in a cohort of spinocerebellar ataxia type-3 (SCA3) carriers using a Simoa assay. Background: Development of…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 27
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley